Tag: Vaccines
White House Approves Tougher Rules for COVID-19 Vaccine Development
Guidelines recommend participants in late-stage trials be followed for a median of at least two months
Poll: Only Half of Americans Would Try to Get COVID-19 Vaccine
If enough people in the U.S. pass on vaccine, the nation may not be able to achieve herd immunity
2018 to 2019 Vaccine Cut Influenza A-Linked Hospitalizations
Influenza vaccine reduced pediatric influenza A-linked hospitalizations, ED visits by 40 to 60 percent
Older Adults Likely to Be Excluded From COVID-19 Trials
Fifty percent of phase 3 clinical trials and 100 percent of vaccine trials at risk for excluding older adults
HPV Vaccination Tied to Decrease in Invasive Cervical Cancer Risk
Incidence rate ratio 0.12 among women vaccinated before age 17; 0.47 for those vaccinated at ages 17 to 30
No Moderna COVID-19 Vaccine Expected Until Next Spring
Company will not be ready to seek U.S. approval for the vaccine until at least late January
~60 Percent of Pregnant Women Got Flu Shot in 2019 to 2020
56.6 percent received Tdap in pregnancy; highest cover seen with provider offer, referral for vaccination
Only Two-Thirds of Parents Planning to Get Flu Shots for Their Children
Despite the COVID-19 pandemic, only one-third of parents see the flu vaccine as more necessary this year
ACIP Provides Recommendations on Meningococcal Vaccination
Vaccination with MenACWY recommended for adolescents aged 11 to 12 years with booster at 16 years
Chinese Company Says Its COVID-19 Vaccine Should Be Available in U.S. in Early 2021
If it passes final round of human tests, SinoVac will apply to the FDA to sell CoronaVac vaccine
